Private investors, including venture capitalists and angel investors, play a significant role in driving innovation in cancer treatment. By funding biotech startups and pharmaceutical companies, they help bring cutting-edge therapies to market. This not only accelerates the availability of new treatments but also fosters a competitive environment that encourages continuous improvement and cost reduction.